BridgeMD
Tests treatment safety and results for Menopause
Official title Efficacy of Nano-Pso Therapy in Menopause
ClinicalTrials.gov ID: NCT06432816
What this study is testing
- What it's testing
- Vasomotor syndrome is prevalent in 85% of postmenopausal women, hormone therapy in menopause is first-line therapy, but 38% of patients have some contraindication for its use. The medications indicated in this population presents adverse reactions, such as dryness of the mucous membranes, and insomnia in patients, and triggers to abandoned treatment due to poor response to the drug.
- You might receive a placebo (an inactive treatment) instead of the study drug.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 45 to 55, women only. Healthy volunteers may be eligible.
You may be able to join if
- In perimenopause with vasomotor syndrome and score greater than 15 points staged with the MRS scale
- They agree to participate and sign the consent informed.
- Without prior treatment to relieve the symptoms of menopause.
You likely can't join if
- \- With pharmacological and/or hormonal therapy prescribed for menopause symptoms.
- With psychiatric pathologies such as anxiety and depression.
- Hysterectomized patients or patients with induced menopause surgically early.
- Smoking
- Malnutrition or low weight determined by a BMI ≤ 18.5Kg/m2 Elimination criteria.
- Who do not attend follow-up to provide their treatment the 1, 2, 3 and 4 months for application of the MRS scale
See the full eligibility criteria
- In perimenopause with vasomotor syndrome and score greater than 15 points staged with the MRS scale
- They agree to participate and sign the consent informed.
- Without prior treatment to relieve the symptoms of menopause.
- \- With pharmacological and/or hormonal therapy prescribed for menopause symptoms.
- With psychiatric pathologies such as anxiety and depression.
- Hysterectomized patients or patients with induced menopause surgically early.
- Smoking
- Malnutrition or low weight determined by a BMI ≤ 18.5Kg/m2 Elimination criteria.
- Who do not attend follow-up to provide their treatment the 1, 2, 3 and 4 months for application of the MRS scale
- That they leave the study voluntarily.
- Who present any serious adverse effect to the drug.
The study team makes the final eligibility decision.
Where it's taking place
- Toluca, State of Mexico, Mexico
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 45 years to 55 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Toluca, State of Mexico, Mexico. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.